Oramed Pharmaceuticals Debt to Equity Ratio 2011-2024 | ORMP
Current and historical debt to equity ratio values for Oramed Pharmaceuticals (ORMP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Oramed Pharmaceuticals debt/equity for the three months ending December 31, 2024 was 0.00.
| Oramed Pharmaceuticals Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.01B | $0.15B | 0.07 |
| 2024-09-30 | $0.01B | $0.16B | 0.06 |
| 2024-06-30 | $0.01B | $0.18B | 0.05 |
| 2024-03-31 | $0.04B | $0.17B | 0.23 |
| 2023-12-31 | $0.06B | $0.16B | 0.35 |
| 2023-09-30 | $0.08B | $0.15B | 0.56 |
| 2023-06-30 | $0.01B | $0.15B | 0.04 |
| 2023-03-31 | $0.01B | $0.15B | 0.06 |
| 2022-12-31 | $0.01B | $0.15B | 0.07 |
| 2022-09-30 | $0.01B | $0.15B | 0.07 |
| 2022-06-30 | $0.01B | $0.15B | 0.06 |
| 2022-03-31 | $0.01B | $0.16B | 0.06 |
| 2021-12-31 | $0.01B | $0.17B | 0.07 |
| 2021-11-30 | $0.01B | $0.17B | 0.07 |
| 2021-09-30 | $0.00B | 0.00 | |
| 2021-08-31 | $0.01B | $0.12B | 0.10 |
| 2021-06-30 | $0.00B | 0.00 | |
| 2021-05-31 | $0.01B | $0.07B | 0.16 |
| 2021-03-31 | $0.00B | 0.00 | |
| 2021-02-28 | $0.01B | $0.05B | 0.25 |
| 2020-11-30 | $0.01B | $0.03B | 0.45 |
| 2020-08-31 | $0.01B | $0.03B | 0.36 |
| 2020-05-31 | $0.01B | $0.03B | 0.35 |
| 2020-02-29 | $0.01B | $0.02B | 0.86 |
| 2019-11-30 | $0.01B | $0.02B | 0.82 |
| 2019-08-31 | $0.02B | $0.02B | 0.79 |
| 2019-05-31 | $0.02B | $0.02B | 0.74 |
| 2019-02-28 | $0.02B | $0.03B | 0.65 |
| 2018-11-30 | $0.02B | $0.03B | 0.51 |
| 2018-08-31 | $0.02B | $0.03B | 0.52 |
| 2018-05-31 | $0.02B | $0.02B | 1.08 |
| 2018-02-28 | $0.02B | $0.02B | 0.87 |
| 2017-11-30 | $0.02B | $0.02B | 0.83 |
| 2017-08-31 | $0.02B | $0.02B | 1.01 |
| 2017-05-31 | $0.02B | $0.02B | 1.01 |
| 2017-02-28 | $0.02B | $0.02B | 0.96 |
| 2016-11-30 | $0.02B | $0.02B | 0.87 |
| 2016-08-31 | $0.02B | $0.03B | 0.64 |
| 2016-05-31 | $0.01B | $0.03B | 0.17 |
| 2016-02-29 | $0.01B | $0.03B | 0.17 |
| 2015-11-30 | $0.00B | $0.02B | 0.06 |
| 2015-08-31 | $0.00B | $0.03B | 0.06 |
| 2015-05-31 | $0.00B | $0.02B | 0.04 |
| 2015-02-28 | $0.00B | $0.02B | 0.03 |
| 2014-11-30 | $0.00B | $0.02B | 0.04 |
| 2014-08-31 | $0.00B | $0.02B | 0.05 |
| 2014-05-31 | $0.00B | $0.02B | 0.02 |
| 2014-02-28 | $0.00B | $0.02B | 0.02 |
| 2013-11-30 | $0.00B | $0.01B | 0.10 |
| 2013-08-31 | $0.00B | $0.01B | 0.07 |
| 2013-05-31 | $0.00B | $0.00B | 0.17 |
| 2013-02-28 | $0.00B | $0.01B | 0.14 |
| 2012-12-31 | $0.00B | 0.00 | |
| 2012-11-30 | $0.00B | $0.01B | 0.09 |
| 2012-08-31 | $0.00B | $0.00B | 0.40 |
| 2012-05-31 | $0.00B | $0.00B | 0.26 |
| 2012-02-29 | $0.00B | $0.00B | 0.31 |
| 2011-11-30 | $0.00B | $0.00B | 0.18 |
| 2011-09-30 | $0.00B | 0.00 | |
| 2011-08-31 | $0.00B | $0.00B | 0.16 |
| 2011-06-30 | $0.00B | $0.00B | 0.00 |
| 2011-05-31 | $0.00B | 0.00 | |
| 2011-03-31 | $0.00B | 0.00 | |
| 2011-02-28 | $0.00B | 0.00 | |
| 2010-12-31 | $0.00B | $0.00B | 0.00 |
| 2010-11-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.092B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.641B | 27.61 |
| Boston Scientific (BSX) | United States | $152.191B | 38.10 |
| Stryker (SYK) | United States | $148.126B | 30.97 |
| EssilorLuxottica (ESLOY) | France | $127.448B | 0.00 |
| Medtronic (MDT) | Ireland | $110.055B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.786B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.281B | 27.46 |
| ResMed (RMD) | United States | $36.314B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.934B | 16.11 |
| Agilent Technologies (A) | United States | $32.944B | 21.76 |
| Terumo (TRUMY) | Japan | $28.086B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.536B | 16.92 |
| Insulet (PODD) | United States | $22.286B | 87.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.433B | 12.48 |
| Baxter (BAX) | United States | $16.360B | 12.22 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.190B | 24.31 |
| Lantheus Holdings (LNTH) | United States | $5.502B | 13.88 |
| Prestige Consumer Healthcare (PBH) | United States | $4.350B | 19.43 |
| Perrigo (PRGO) | Ireland | $3.711B | 9.40 |
| ICU Medical (ICUI) | United States | $3.552B | 26.20 |
| Haemonetics (HAE) | United States | $3.528B | 15.37 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.144B | 26.13 |
| QuidelOrtho (QDEL) | United States | $2.531B | 17.41 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 18.12 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| AtriCure (ATRC) | United States | $1.575B | 0.00 |
| Neogen (NEOG) | United States | $1.411B | 18.06 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Kestra Medical Technologies (KMTS) | United States | $1.211B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.152B | 25.91 |
| BioLife Solutions (BLFS) | United States | $1.135B | 0.00 |
| InMode (INMD) | Israel | $1.043B | 9.55 |
| Phibro Animal Health (PAHC) | United States | $0.992B | 12.69 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.552B | 4.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.545B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.462B | 0.00 |
| Surmodics (SRDX) | United States | $0.387B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.357B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Sanara MedTech (SMTI) | United States | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.268B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.261B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.70 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.222B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.29 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 51.94 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.82 |
| Jin Medical (ZJYL) | China | $0.141B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Agape ATP (ATPC) | $0.083B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.76 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |